Literature DB >> 29937162

Beyond T, N and M: The impact of tumor deposits on the staging and treatment of colorectal and gastric carcinoma.

Nadia Peparini1.   

Abstract

This review aims to describe the results of the most recent studies on the prognostic value of TDs and highlight the impact of TDs on the staging and treatment of colorectal and gastric carcinoma. For colorectal carcinoma TDs have an adverse prognostic effect that is at least similar to that of positive regional lymph nodes. However, support is growing in favor of including of TDs in the M category, rather than the N or T categories of the TNM classification. Moreover, TDs seem to have an adverse effect on outcomes not only in patients without lymph node involvement but also in patients with nodal involvement. Although the prognostic impact of TDs in gastric cancer appears to be undeniable, the actual prognostic determinants of TDs, particularly in relation to the number, size and histological types, remain to be established. Although the 7th and 8th Edition of the TNM classification of colorectal and gastric carcinoma includes TDs in the N category, no current procedures or methods to assess preoperative or intraoperative N-status allow TD detection. After neoadjuvant treatment for advanced rectal carcinoma, the presence of TDs may indicate incomplete eradication of the main tumor and not discontinuous tumor foci. TDs have an undeniable prognostic impact but no algorithm of staging and strategy of treatment has been conformed to this prognostic factor to overcome the classical T,N, and M prognostic categories. Staging and treatment of colorectal and gastric cancers should be reconsidered in light of the emerging prognostic value of TDs.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Colorectal cancer; Gastric cancer; Tumor deposits

Mesh:

Year:  2018        PMID: 29937162     DOI: 10.1016/j.suronc.2018.02.007

Source DB:  PubMed          Journal:  Surg Oncol        ISSN: 0960-7404            Impact factor:   3.279


  6 in total

1.  Circulating CD16+CD56+ nature killer cells indicate the prognosis of colorectal cancer after initial chemotherapy.

Authors:  Feng Cui; Di Qu; Ruya Sun; Kejun Nan
Journal:  Med Oncol       Date:  2019-09-06       Impact factor: 3.064

2.  Prognostic targets recognition of rectal adenocarcinoma based on transcriptomics.

Authors:  Xingcheng Yi; Yulai Zhou; Hanyu Zheng; Luoying Wang; Tong Xu; Cong Fu; Xiaoyun Su
Journal:  Medicine (Baltimore)       Date:  2021-08-13       Impact factor: 1.817

3.  Tumor deposit serves as a prognostic marker in gastric cancer: A propensity score-matched analysis comparing survival outcomes.

Authors:  Liang Wenquan; Liu Yuhua; Cui Jianxin; Xi Hongqing; Zhang Kecheng; Li Jiyang; Gao Yunhe; Liu Yi; Zhang Wang; Li Shaoqing; Lu Yixun; Qiao Shen; Xue Wanguo; Qiao Zhi; Chen Lin
Journal:  Cancer Med       Date:  2020-03-12       Impact factor: 4.452

4.  A Six-microRNA Signature Nomogram for Preoperative Prediction of Tumor Deposits in Colorectal Cancer.

Authors:  Zhikang Chen; Chen Lai; Shihan Xiao; Jianping Guo; Wuming Zhang; Xianqin Hu; Ran Wang
Journal:  Int J Gen Med       Date:  2022-01-18

5.  Clinicopathological factors associated with the presence of tumor deposits in resected gastric cancer patients.

Authors:  Oscar Paredes Torres; Sofia Prado Cucho; Luis Taxa Rojas; Carlos Luque-Vasquez; Ivan Chavez; Eduardo Payet Meza; Eloy Ruiz Figueroa; Francisco Berrospi Espinoza
Journal:  Heliyon       Date:  2021-05-29

6.  Tumour deposits are a significant prognostic factor in gastric cancer - a systematic review and meta-analysis.

Authors:  Cristina Graham Martínez; Nikki Knijn; Marcel Verheij; Iris D Nagtegaal; Rachel S van der Post
Journal:  Histopathology       Date:  2019-02-10       Impact factor: 5.087

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.